Skip to main content

Table 5 Utility values

From: Cost-effectiveness of human papillomavirus vaccination in Germany

Health state Utility value Duration Source
Treatment of CIN 1 0.91 2 months [47]
Treatment of CIN 2 0.87 2 months [47]
Treatment of CIN 3 0.87 2 months [47]
Treatment of CIS 0.80 2 months [48]
Follow-up of CIS 0.97 1.8 years (22 months) [48]
Treatment of FIGO I 0.65 6 months [87]
Follow-up of FIGO I 0.97 Up to 4.5 years (54 months) [48, 87]
Treatment of FIGO II 0.56 6 months [87]
Follow-up of FIGO II 0.90 Up to 4.5 years (54 months) [48, 87]
Treatment of FIGO III 0.56 6 months [87]
Follow-up of FIGO III 0.90 Up to 4.5 years (54 months) [48, 87]
Treatment of FIGO IV 0.48 6 months [88]
Follow-up of FIGO IV 0.62 Up to 4.5 years (54 months) [48, 87]
Palliative care 0.29 1 month [89]
Treatment of genital warts 0.93 2 months [46, 48] (mean value of both sources)
  1. CIN cervical intraepithelial neoplasia, CIS carcinoma in situ, FIGO International Federation of Gynecology and Obstetrics